114 related articles for article (PubMed ID: 37571819)
1. FAM64A aggravates proliferation, invasion, lipid droplet formation, and chemoresistance in gastric cancer: A biomarker for aggressiveness and a gene therapy target.
Yun WJ; Zhang L; Yang N; Cui ZG; Jiang HM; Ha MW; Yu DY; Zhao MZ; Zheng HC
Drug Dev Res; 2023 Nov; 84(7):1537-1552. PubMed ID: 37571819
[TBL] [Abstract][Full Text] [Related]
2. ING5 suppresses proliferation, apoptosis, migration and invasion, and induces autophagy and differentiation of gastric cancer cells: a good marker for carcinogenesis and subsequent progression.
Gou WF; Shen DF; Yang XF; Zhao S; Liu YP; Sun HZ; Su RJ; Luo JS; Zheng HC
Oncotarget; 2015 Aug; 6(23):19552-79. PubMed ID: 25980581
[TBL] [Abstract][Full Text] [Related]
3. A bioinformatics analysis of the clinicopathological and prognostic significance of
Zheng HC; Ren DH; Zhang CY; Chen Y; Zhang L
J Obstet Gynaecol; 2023 Dec; 43(1):2216280. PubMed ID: 37227120
[TBL] [Abstract][Full Text] [Related]
4. Knockdown of FAM64A suppresses proliferation and migration of breast cancer cells.
Yao Z; Zheng X; Lu S; He Z; Miao Y; Huang H; Chu X; Cai C; Zou F
Breast Cancer; 2019 Nov; 26(6):835-845. PubMed ID: 31264076
[TBL] [Abstract][Full Text] [Related]
5. BTG1 expression correlates with pathogenesis, aggressive behaviors and prognosis of gastric cancer: a potential target for gene therapy.
Zheng HC; Li J; Shen DF; Yang XF; Zhao S; Wu YZ; Takano Y; Sun HZ; Su RJ; Luo JS; Gou WF
Oncotarget; 2015 Aug; 6(23):19685-705. PubMed ID: 26050197
[TBL] [Abstract][Full Text] [Related]
6. Regenerating gene 4 promotes chemoresistance of colorectal cancer by affecting lipid droplet synthesis and assembly.
Zhang CY; Zhang R; Zhang L; Wang ZM; Sun HZ; Cui ZG; Zheng HC
World J Gastroenterol; 2023 Sep; 29(35):5104-5124. PubMed ID: 37744296
[TBL] [Abstract][Full Text] [Related]
7. Cell Cycle-Related FAM64A Could be Activated by TGF-β Signaling to Promote Glioma Progression.
Fu M; Zhang J; Zhang L; Feng Y; Fang X; Zhang J; Wen W; Hua W; Mao Y
Cell Mol Neurobiol; 2023 Aug; 43(6):2975-2987. PubMed ID: 37081231
[TBL] [Abstract][Full Text] [Related]
8. The promoting effects of GPR176 expression on proliferation, chemoresistance, lipogenesis and invasion of oesophageal cancer.
Yun WJ; Li J; Yin NC; Zhang CY; Cui ZG; Zhang L; Zheng HC
J Cancer Res Clin Oncol; 2023 Nov; 149(16):14641-14655. PubMed ID: 37584712
[TBL] [Abstract][Full Text] [Related]
9. The facilitating effects of KRT80 on chemoresistance, lipogenesis, and invasion of esophageal cancer.
Yun WJ; Li J; Yin NC; Zhang CY; Cui ZG; Zhang L; Zheng HC
Cancer Biol Ther; 2024 Dec; 25(1):2302162. PubMed ID: 38241178
[TBL] [Abstract][Full Text] [Related]
10. The roles of BTG3 expression in gastric cancer: a potential marker for carcinogenesis and a target molecule for gene therapy.
Gou WF; Yang XF; Shen DF; Zhao S; Liu YP; Sun HZ; Takano Y; Su RJ; Luo JS; Zheng HC
Oncotarget; 2015 Aug; 6(23):19841-67. PubMed ID: 25904053
[TBL] [Abstract][Full Text] [Related]
11. The altered expression of ING5 protein is involved in gastric carcinogenesis and subsequent progression.
Xing YN; Yang X; Xu XY; Zheng Y; Xu HM; Takano Y; Zheng HC
Hum Pathol; 2011 Jan; 42(1):25-35. PubMed ID: 21062663
[TBL] [Abstract][Full Text] [Related]
12. FOXD1-AS1 regulates FOXD1 translation and promotes gastric cancer progression and chemoresistance by activating the PI3K/AKT/mTOR pathway.
Wu Q; Ma J; Wei J; Meng W; Wang Y; Shi M
Mol Oncol; 2021 Jan; 15(1):299-316. PubMed ID: 32460412
[TBL] [Abstract][Full Text] [Related]
13. Alpha B-crystallin promotes the invasion and metastasis of gastric cancer via NF-κB-induced epithelial-mesenchymal transition.
Chen D; Cao G; Qiao C; Liu G; Zhou H; Liu Q
J Cell Mol Med; 2018 Jun; 22(6):3215-3222. PubMed ID: 29566309
[TBL] [Abstract][Full Text] [Related]
14. HKDC1 upregulation promotes glycolysis and disease progression, and confers chemoresistance onto gastric cancer.
Wang MQ; Chen YR; Xu HW; Zhan JR; Suo DQ; Wang JJ; Ma YZ; Guan XY; Li Y; Zhu SL
Cancer Sci; 2023 Apr; 114(4):1365-1377. PubMed ID: 36519789
[TBL] [Abstract][Full Text] [Related]
15. KRT80 expression works as a biomarker and a target for differentiation in gastric cancer.
Shi KH; Xue H; Zhao EH; Xiao LJ; Sun HZ; Zheng HC
Histol Histopathol; 2024 Jan; 39(1):117-130. PubMed ID: 37129345
[TBL] [Abstract][Full Text] [Related]
16. FAM64A is an androgen receptor-regulated feedback tumor promoter in prostate cancer.
Zhou Y; Ou L; Xu J; Yuan H; Luo J; Shi B; Li X; Yang S; Wang Y
Cell Death Dis; 2021 Jul; 12(7):668. PubMed ID: 34215720
[TBL] [Abstract][Full Text] [Related]
17. Block of Proliferation 1 Promotes Proliferation, Invasion and Epithelial Mesenchymal Transformation in Gastric Cancer.
He J; Chen Z; Xue Q; Shi W
Oxid Med Cell Longev; 2022; 2022():2946989. PubMed ID: 35222794
[TBL] [Abstract][Full Text] [Related]
18. [CircPCSK5 is highly expressed in gastric cancer and promotes cancer cell proliferation, invasion and epithelial-mesenchymal transition].
Zuo X; Cai J; Chen Z; Li Y; Zhang D
Nan Fang Yi Ke Da Xue Xue Bao; 2022 Oct; 42(10):1440-1451. PubMed ID: 36329577
[TBL] [Abstract][Full Text] [Related]
19. Up-regulation of FAM64A promotes epithelial-to-mesenchymal transition and enhances stemness features in breast cancer cells.
Zhang J; Qian L; Wu J; Lu D; Yuan H; Li W; Ying X; Hu S
Biochem Biophys Res Commun; 2019 May; 513(2):472-478. PubMed ID: 30979502
[TBL] [Abstract][Full Text] [Related]
20. NANOGP8 is the key regulator of stemness, EMT, Wnt pathway, chemoresistance, and other malignant phenotypes in gastric cancer cells.
Ma X; Wang B; Wang X; Luo Y; Fan W
PLoS One; 2018; 13(4):e0192436. PubMed ID: 29689047
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
